RE:RE:RE:RE:RE:RE:RE:RE:RE:Quiet hereFYI -- I check with NFG Investor Relations immediately after the announcment of ES investment and they confirmed that this financing would NOT impact/delay the release of any ongoing PR's (including assays).
This was of particular interest as long delays with no news whatsoever (ie past summer) can impact the share priceI considerably so this seemed to me to be particularly good news.
The $48M financing announcement said it required SIC approval that may or may not require shareholder approval to allow ES to exceed 20% ownership,. NFG does not immediately need ES money and the deal has already been negotiated/agreed upon so the rest is administrative process to cross t's, dot i's for admin approvals.
Based on IR input, I expect that NFG mgmt is not holding back any PR's as a result of this financing.
Whether they are holding back PR's for other reasons is a mgmt timing issue and they have done an excellent job of it so far --- but not due to the ES financing.